CLINICAL_TRIALS
trial_result
· 2014-10-29
Clinical Trial Update: End-Tidal Carbon Dioxide as a Measure of Carboxyhemoglobin in Carbon Monoxide Poisoning
Summary
A completed clinical trial evaluated end-tidal carbon dioxide as a potential measure of carboxyhemoglobin in individuals with carbon monoxide poisoning.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Hennepin Healthcare Research Institute | Conditions: Carbon Monoxide Exposure | Status: COMPLETED